Connor, Clark & Lunn Investment Management Ltd.
Position in SRPT — Sarepta Therapeutics, Inc.
CIK 1596800
VANCOUVER, A1
Position in SRPT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$17,493,669
-$4,700,464 QoQ
Shares Held
973,493
-4.6% QoQ
Ownership
0.922%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#23
of 323 holders
Holding Since
Sep 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Connor, Clark & Lunn Investment Management Ltd. holds $648,992,404 across 104 Biotechnology names. SRPT ranks #12 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
135,236 | $67,175,777 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
684,236 | $54,253,072 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
625,569 | $50,990,129 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
420,063 | $49,176,775 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
42,465 | $26,478,625 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
97,698 | $23,913,539 | |
| 7 | INSM |
INSMED Inc
|
212,676 | $22,675,515 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
530,607 | $20,698,979 |
All Filings in SRPT
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,493,669 | 973,493 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $22,194,133 | 1,019,951 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $23,301,038 | 1,082,762 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $33,627,132 | 1,745,051 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $10,524,041 | 615,441 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $15,621,157 | 244,769 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $17,902,425 | 147,236 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $9,771,893 | 78,244 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $9,503,542 | 60,149 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $265,781 | 2,053 | Shares | Sole | 2024-05-09 | |
| 2023-09-30 | $9,523,770 | 78,566 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $11,239,336 | 98,143 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $16,493,564 | 119,666 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $15,069,635 | 116,296 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $17,435,584 | 157,731 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,337,361 | 17,841 | Shares | Sole | 2022-08-05 | |
| 2021-03-31 | $386,363 | 5,184 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,271,173 | 7,456 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,193,233 | 8,497 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||